Delta-Fly Pharma Reports Six-Month Net Loss of 802 Million Yen

Delta-Fly Pharma reported a six-month parent net loss of 802 million yen, versus a loss of 841 million yen. Its 2026/27 forecast is a loss of 1.35 billion yen.